Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Drugs in Pipeline
4
Phase 3 Programs
0
Upcoming Catalysts
2
Next Catalyst
Jun 15, 2026
25w| Drug Name | Phase |
|---|---|
Sevasemten Dose 2 | Phase 2 |
EDG-7500 | Phase 2 |
Sevasemten 10 mg | Phase 2 |
Sevasemten Dose 1 | Phase 2 |
2 upcoming, 0 past
Primary completion for EDG-7500 trial (NCT06347159) in Hypertrophic Cardiomyopathy
SourcePrimary completion for Sevasemten 10 mg trial (NCT05291091) in Becker Muscular Dystrophy
Source